News
Latest news
ArgusEye Makes It On ’33-Listan’ for the Third Time – Achieves ‘Gold Company’ Status
For the third consecutive year, ArgusEye has secured a spot [...]
The Purpose Behind the Auga™ Platform
At ArgusEye, we are dedicated to revolutionizing biopharmaceutical processing by offering [...]
ArgusEye closes €2.8 million funding to accelerate bioprocessing
Today we’re announcing an oversubscribed funding round of 2.8 M [...]
News
ArgusEye introduces AugaOne™ to accelerate downstream bioprocess development
• AugaOne™ sensor system provides specific, real-time, and automated data to reduce mAb process development time • New sensor will be exhibited at the Bioprocessing Summit, 18-21 March 2024, booth 66 Linköping, Sweden, 21 March 2024: ArgusEye, a provider of innovative sensor solutions for [...]
The Countdown Begins: Just Two Months Until the Exciting Launch of AugaOne™!
With the product launch swiftly approaching, ArgusEye offers an exclusive sneak peek of the AugaOne™ system. ArgusEye is set to unveil its first official product at the 7th Bioprocessing Summit in Barcelona on March 21st. With only 2 months to [...]
ArgusEye – Among the Top 33 Tech Startups in Sweden, Once Again!
For the second consecutive year, ArgusEye proudly secures its place on the esteemed “33-listan” by the Swedish tech magazine Ny Teknik. This prestigious list recognizes Sweden’s most promising and innovative young tech companies. Since 2008, the Swedish tech magazine Ny Teknik, has annually highlighted the [...]
ArgusEye signs agreement with Optronic for intensified product development and increased manufacturing capacity
ArgusEye has recently entered into a strategic collaboration agreement with Optronic, an external partner specializing in product development and manufacturing. "We have been searching for a partner capable of manufacturing our hardware components while also providing support for our future product development. It feels [...]
ArgusEye – one of Sweden’s top Startups 2022
ArgusEye has been listed in the prestigious 33-listan by the Swedish tech magazine Ny Teknik, which acknowledges the most promising and innovative young tech companies in Sweden. Since 2008, the Swedish tech magazine Ny Teknik, has listed the 33 best young tech companies in [...]
ArgusEye closes deal with the downstream group within biological development at Bayer AG
The multinational pharmaceutical and biotechnology company, Bayer AG, has decided to purchase an in-line sensor system from ArgusEye AB (Linköping, Sweden) to accelerate their development of new therapies based on biopharmaceuticals. The sensor system, ArgusOne, developed and provided by ArgusEye enables faster and more [...]
Another successful week for ArgusEye during TESTA Challenge 2022
During March 14 – April 1, ArgusEye participated in the second edition of TESTA Challenge in Uppsala. This event is organized by TESTA Center in collaboration with STUNS, Cytiva, PALL Corporation and RISE with the objective to allow companies to validate new and innovative [...]
ArgusEye selected for TESTA Challenge 2022
ArgusEye has again been selected to participate in TESTA Challenge hosted by TESTA Center in Uppsala, Sweden. This is the second edition of TESTA Challenge which is organized by TESTA Center and STUNS in collaboration with Cytiva. RISE and Pall. The aim of this [...]
ArgusEye completes oversubscribed seed funding round
ArgusEye has successfully completed its first external financing round, securing additional funding for further product development and team expansion. The strong investor syndicate in this oversubscribed funding round is led by Eir Ventures and ALMI Invest together with 10 life science experienced business angels. NY [...]
A successful week for ArgusEye during TESTA Challenge 2020
During October 19-23, ArgusEye participated in TESTA Challenge in Uppsala. This is a new initiative organized by TESTA Center, STUNS and Cytiva. The objective is to allow small start-up companies (like ArgusEye) to validate new and innovative methods and technologies to improve the production [...]